Eton Pharmaceuticals is pleased to announce that the Food and Drug Administration has approved its new drug application for ET-400, a form of hydrocortisone oral solution. Consequently, the company’s stock has risen by 11% in after-hours trading, reaching $3.72. This is a significant milestone for the Deer Park, Illinois-based company.
In separate news, Match Group has attracted the interest of activist investor Starboard Value, who has taken decisive action. According to reports from The Wall Street Journal, Starboard Value is contemplating the potential sale of the online-dating company if a successful turnaround seems improbable. Subsequently, Match Group’s shares have surged by 8% in after-hours trading, reaching $34.60.
Moreover, Trump Media & Technology Group has faced a series of developments. The stock initially experienced a substantial increase during the regular trading session, rising by approximately a third, following an unsuccessful assassination attempt on former President Donald Trump. However, the situation took a downturn after the market closed, with shares plummeting by 10% in after-hours trading to $36.50.
In summary, it is apparent that these three companies – Eton Pharmaceuticals, Match Group, and Trump Media & Technology Group – are undergoing significant shifts. It will be intriguing to monitor the unfolding of these events and their impact on their respective stocks in the immediate future.
– Connor Hart
(Dow Jones Newswires)